Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemia

EMBO Mol Med. 2020 Aug 7;12(8):e12911. doi: 10.15252/emmm.202012911.

Abstract

Publication types

  • Published Erratum